Your browser doesn't support javascript.
loading
Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by ZHER2-Idarubicin Conjugate: An in vitro Study.
Siavoshinia, Leila; Jamalan, Mostafa; Zeinali, Majid; Pourshohod, Aminollah; Koushki, Mahdie; Moradipoodeh, Bahman; Mohammadzadeh, Ghorban.
Afiliación
  • Siavoshinia L; Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Jamalan M; Department of Biochemistry, Abadan Faculty of Medical Sciences, Abadan, Iran.
  • Zeinali M; Biotechnology Research Center, Research Institute of Petroleum Industry (RIPI), Tehran, Iran.
  • Pourshohod A; Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Koushki M; Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Moradipoodeh B; Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Mohammadzadeh G; Hyperlipidemia Research Center, Department of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Iran J Pathol ; 16(2): 109-118, 2021.
Article en En | MEDLINE | ID: mdl-33936221
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Iran J Pathol Año: 2021 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Iran J Pathol Año: 2021 Tipo del documento: Article País de afiliación: Irán